The Nootropic Evidence Guide
The line between nootropic and wishful thinking is blurry and full of sellers. Here’s how to tell real cognitive science from a clever label. Education, not medical advice.
1. Acute effect vs lasting change
Feeling sharper for an afternoon is not the same as improving cognition. Many compounds produce a noticeable acute effect (and tolerance) without any durable benefit. Ask which one is being claimed.
2. The evidence is usually thin
For most nootropic peptides and compounds, human data is small, short, or absent. Semax and Selank have more research interest than most, and still plenty of open questions.
- Small or animal-only studies dominate this space.
- Subjective “it works” reports are easily fooled by placebo.
- Stacking makes any single effect impossible to attribute.
3. Source and dose are unknowns
Cognitive compounds carry the same sourcing risk as any peptide: you often don’t know what’s in the vial. Purity and identity matter before any effect can mean anything.
We decode it, weekly.
Cogdiary tells you what actually affects cognition, with the evidence attached, and what’s just a label. Free.
Subscribe free →Cogdiary is independent education and news, not medical advice. Nothing here is a recommendation to buy, use, or dose any compound. Talk to a qualified clinician about your health.